Dergiler / Uluslararası Hematoloji-Onkoloji Dergisi / 2020 / Cilt: 30 - Sayı: 3

Invasive Fungal Infections in Children with Acute Lymphoblastic Leukemia: Experience from a Reference University Hospital in Cappadocia

Sayfa
126–132
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

With careful assessment of the patients bearing risk factors for IFI development, early diagnosis and treatment will reduce morbidity and mortality.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Invasive fungal infections (IFI) are an important cause of mortality and morbidity in patients with hematological malignancy.
📊
Temel Bulgular & Veri:Two hundred forty children monitored with the diagnosis of ALL in the pediatric hematology-oncology department of the Erciyes University Medical Faculty from January 2010 to September 2017 included in the study.
💡
Sonuç & Katkı:With careful assessment of the patients bearing risk factors for IFI development, early diagnosis and treatment will reduce morbidity and mortality.
🔬Tür:Araştırma Makalesi
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Invasive fungal infections (IFI) are an important cause of mortality and morbidity in patients with hematological malignancy. This study aims to investigate the incidence of IFI development, risk factors, the management of the infection in a pediatric patient group followed up with the diagnosis of acute lymphoblastic leukemia (ALL), and to share the experience obtained from a single center. Two hundred forty children monitored with the diagnosis of ALL in the pediatric hematology-oncology department of the Erciyes University Medical Faculty from January 2010 to September 2017 included in the study. A total of 30 (14 females and 14 males) IFI attacks were diagnosed (12.5%) in the included patients with ALL, two of them having the attacks twice. Candida species were the dominant cause of infection (n= 17) and the rest (n= 8) had invasive Aspergillosis. Nineteen IFI attacks were assessed as proven, 6 as probable, and 5 as possible IFI. The most fungal infection was detected in blood culture (43.3%) followed by pulmonary involvement (40%). The most frequently used diagnostic methods were direct microscopic examination, histological examination, and cultures (66.6%). IFI-related mortality was 20%. IFI continues to be an important problem in pediatric patients with hematologic malignity. The 7 of the observed invasive Aspergillosis developed in non hepafiltered room. Treatment of neutropenic children in hepafiltered rooms decrease the risk of IFI. With careful assessment of the patients bearing risk factors for IFI development, early diagnosis and treatment will reduce morbidity and mortality.

🔖

Bu Makaleye Atıf Yap

YILMAZ, E., ERDOGMUS, A., OZCAN, A., GÖRKEM, S. B., CEYLAN, Ö., DENİZ, K., ÜNAL, E., ATALAY, M. A., KARAKÜKCÜ, M., KOÇ, A. N., PATIROGLU, T. (2020). Invasive Fungal Infections in Children with Acute Lymphoblastic Leukemia: Experience from a Reference University Hospital in Cappadocia. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 30 - Sayı: 3, 126–132. https://ajindex.com/articles/322737

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Karthaus M, Cornely OA. Recent developments in the management of invasive fungal infections in patients with hematological malignancies. Ann Hematol 84: 207-216, 2005 2. Patiroglu T, Altuner Torun Y, Yikilmaz A, et al. Invasive Pulmonary Aspergillosis Associated With Pleural Effusion and Pneumothorax. Erciyes Med J 30: 48-51, 2008. 3. Celkan T, Kizilocak H, Evim M, et al. Hepatosplenic Fungal Infections in Children With Leukemia-Risk Factors and Outcome: A Multicentric Study. J Pediatr Hematol Oncol 41: 256-260, 2019. 4. Lehrnbecher T, Phillips R, Alexander S, et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol 30: 4427-4438, 2012. 5. Rüping MJ, Vehreschild JJ, Cornely OA. Patients at high risk of invasive fungal infections: when and how to treat. Drugs. 68: 1941-1962, 2008. 6. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 2019 Dec 5. (Online ahead of print) 7. Yuksel Soycan L. BFM-TR ALL 2000: first Turkish multicentric study in the treatment of pediatric acute lymphoblastic leukemia. J Pediatr Hematol Oncol 29: 21, 2007. 8. Uderzo C, Dini G, Locatelli F, et al. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Haematologica 85: 47-53, 2000. 9. Patiroglu T, Unal E, Karakukcu M, et al. Multiple fungal brain abscesses in a child with acute lymphoblastic leukemia. Mycopathologia 174: 505-509, 2012. 10. Canpolat M, Ceylan O, Per H, et al. Brain abscesses in children: results of 24 children from a reference center in Central Anatolia, Turkey. J Child Neurol 30: 458-467, 2015. 11. Arora RS, Arora B. Acute leukemia in children: A review of the current Indian data. South Asian J Cancer 5: 155-160, 2016. 12. Nguyen K, Devidas M, Cheng SC, et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children’s Oncology Group study. Leukemia 22: 2142-2150, 2008. 13. Auberger J, Lass-Flörl C, Ulmer H, et al. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 88: 508-515, 2008. 14. Rosen GP, Nielsen K, Glenn S, et al. Invasive fungal infections in pediatric oncology patien